PLX3397

PLX3397 · Plexxikon

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for PLX3397, covering 2013-03-15 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors [Phase 1, Phase 2]